Live Stocks get clobbered as Trump's China trade war intensifies. See the latest. Munich - Delayed Quote • EUR Ono Pharmaceutical Co., Ltd. (ON4.MU) Follow Compare 10.00 -0.10 (-0.99%) At close: 5:27:05 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for ON4.MU 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: ON4.MU View More All News Press Releases SEC Filings Ionis Pharmaceuticals Partners With Japan-Based Ono Pharmaceutical For Rare Blood Disease Drug In Over $800 Million Deal Ionis Out-Licenses Rights for Rare Blood Cancer Drug to Ono FATE Q4 Earnings Beat, Autoimmunity, Oncology Programs in Focus Ono’s TGCT therapy wins FDA approval, challenging Daiichi Sankyo ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion Deciphera Catapults 73% On Ono Pharmaceutical's $2.4 Billion Takeover Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn Deciphera to sell for $2.4B, adding to upswing in biopharma M&A UPDATE 2-Japan's Ono to buy US drugmaker Deciphera for $2.4 bln Related Tickers RHHBF Roche Holding AG 304.50 +2.87% AZN AstraZeneca PLC 64.87 -2.83% BMY Bristol-Myers Squibb Company 50.46 -6.10% MRK Merck & Co., Inc. 77.55 -5.32% PFE Pfizer Inc. 21.59 -4.00%